You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MART Peptide

Showing 1 - 25 of 2,013
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin) Trial in Tampa (MART-1, NY-ESO-1, gp100:209-217(210M))

Completed
  • Melanoma (Skin)
  • MART-1
  • +5 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 17, 2023

Metastatic Melanoma Trial in Los Angeles (F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells, non-myeloablative

Completed
Has Results
  • Metastatic Melanoma
  • F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells
  • non-myeloablative conditioning chemotherapy
  • Los Angeles, California
    University of California Los Angeles, David Geffen School of Med
Dec 3, 2021

Melanoma Trial in New York (DC Vaccine, Montanide Vaccine, Poly-ICLC)

Completed
  • Melanoma
  • DC Vaccine
  • +2 more
  • New York, New York
  • +1 more
Sep 13, 2022

Melanoma Trial in Los Angeles (dendritic cell-MART-1 peptide vaccine, leukapheresis)

Completed
  • Melanoma
  • dendritic cell-MART-1 peptide vaccine
  • leukapheresis
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

Melanoma (Skin) Trial in Los Angeles (dendritic cell-MART-1 peptide vaccine)

Completed
  • Melanoma (Skin)
  • dendritic cell-MART-1 peptide vaccine
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

Stage IIA Skin Melanoma, Stage IIB Skin Melanoma, Stage IIC Skin Melanoma Trial in Rochester (biological, drug, other)

Completed
  • Stage IIA Skin Melanoma
  • +6 more
  • MART-1 Antigen
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 13, 2020

Melanoma (Skin) Trial in Los Angeles (maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 mAb)

Completed
  • Melanoma (Skin)
  • maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 30, 2020

Melanoma Trial in Lausanne, Geneva (Melan-A ELA + Montanide, Melan-A ELA + NY-ESO-1b + MAGE-A10 + Montanide, Melan-A -ELA +

Completed
Has Results
  • Melanoma
  • Melan-A ELA + Montanide
  • +4 more
  • Lausanne, Vaud, Switzerland
  • +1 more
Jun 2, 2020

Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP

Completed
Has Results
  • Prostate Specific Antigens
  • Prostate Neoplasms
  • T-cell receptor alternate reading frame protein (TARP) peptide vaccine
  • T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022

Melanoma (Skin) Trial in Rochester (MART-1 antigen, IL-2, gp100 antigen)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Feb 15, 2019

MDD Trial in Toronto (Soterix Medical tDCS mini-Clinical Trials system (mini-CT), Computerized CBT (cCBT))

Active, not recruiting
  • Major Depressive Disorder
  • Soterix Medical tDCS mini-Clinical Trials system (mini-CT)
  • Computerized CBT (cCBT)
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Mar 4, 2022

Recurrent Melanoma, Stage IIA Melanoma, Stage IIB Melanoma Trial in Rochester (drug, biological, other)

Completed
  • Recurrent Melanoma
  • +7 more
  • Montanide ISA 51 VG
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 4, 2018

Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

Completed
  • Leukemia, Chronic Lymphatic
  • Stuttgart, Baden-Wuerttemberg, Germany
  • +4 more
Nov 24, 2022

Type 2 Diabetes, Multiple Dose Insulin Therapy Trial (Personalized treatment)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Multiple Dose Insulin Therapy
  • Personalized treatment
  • (no location specified)
Nov 18, 2023

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • (no location specified)
Oct 16, 2023

Trigeminal Neuralgia Trial (trigminal nerve block with RFT)

Not yet recruiting
  • Trigeminal Neuralgia
  • trigminal nerve block with RFT
  • (no location specified)
Jan 29, 2023

Child, Pain, Fear Trial (suturing procedure)

Not yet recruiting
  • Child
  • +4 more
  • suturing procedure
  • (no location specified)
Sep 13, 2022

Pulmonary Arterial Hypertension Participants Treated With

Recruiting
  • Pulmonary Arterial Hypertension
  • PAH medication
  • Acquaviva Delle Fonti, Italy
  • +34 more
Feb 1, 2023

Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)

Completed
  • Type 1 Diabetic Nephropathy
  • oral sitagliptin supplementation
  • Cairo, Egypt
    Nancy Elbarbary
Nov 2, 2023

Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)

Recruiting
  • Migraine
  • +3 more
  • Click Digital Therapeutic
  • New York, New York
    Click Therapeutics
Aug 15, 2023

Obesity Trial in Hellerup (LEAP-2 Protein, Human)

Recruiting
  • Obesity
  • LEAP-2 Protein, Human
  • Hellerup, Capital Region, Denmark
    Center for Clinical Metabolic Research, Gentofte Hospital
Oct 31, 2022

Hypertension, Hypertension, Essential Trial in Nashville (Angiotensin (1-7), Trimethaphan, Phenylephrine)

Active, not recruiting
  • Hypertension
  • Hypertension, Essential
  • Angiotensin (1-7)
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University
Jan 2, 2023

White Spot Lesion Trial in Alexandria (Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR, Fluoride

Completed
  • White Spot Lesion
  • Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR
  • Fluoride varnish (DURAFLOR
  • Alexandria, Egypt
    Alexandria Faculty of Dentistry
Feb 1, 2023

Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Neuroendocrine Neoplasm
  • Arterial Embolization
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Dec 22, 2022